Influenza B Victoria lineage candidate vaccine viruses for
vaccine development and production for the southern
hemisphere 2014
26 September 2013 (last updated 24 January 2014)
Parent virus
Candidate vaccine
virus
B/Brisbane/33/2008
Type of
Developing
virus or
institute
reassortant
Wild type virus
NIBSC, UK
Wild type virus
WHO CCs
NIBSC, UK
NIB-58
B/Brisbane/60/2008
NIBSC, UK
NYMC, USA
NIBSC, UK
NYMC BX-31B#
NYMC, USA
NYMC BX-31-CL#
NYMC, USA
CDC, USA
NYMC, USA
CDC, USA
Classical
NYMC BX-33B##
NYMC BX-35
New York
Medical
College,
NYMC, USA
(NYMC) USA NIID, Japan
NYMC, USA
NIBSC, UK
NIID, Japan
###
CDC, USA
NYMC, USA
NYMC BX-37##
Wild type virus
B/HongKong/
259/2010
NIBSC, UK
NYMC BX-31#
NYMC BX-33##
B/Bangladesh/5945/
2009
Available
from
NYMC BX-43#
Classical
Page 1 of 2
CDC, USA
NYMC, USA
NYMC, USA
Parent virus
Candidate vaccine
virus
Type of
Developing
virus or
institute
reassortant
Available
from
NYMC BX-43A#
Classical
NYMC, USA
NYMC, USA
NYMC BX-43B#
Classical
NYMC, USA
NYMC, USA
Wild type virus
CDC, USA
B/Nevada/3/2011
NYMC BX-47##
Classical
NYMC, USA
Wild type virus
NYMC, USA
CDC, USA
CDC, USA
BX-53A###
Classical
NYMC, USA
NYMC, USA
CDC, USA
BX-53B###
Classical
NYMC, USA
NYMC, USA
CDC, USA
NYMC,
USA
NYMC, USA
CDC, USA
B/Texas/2/2013
*BX-53C### ●
#
##
###
Classical
B/Lee/40 backbone parent
B/Panama/45/90 backbone parent
B/Lee/40 and B/Panama/45/90 backbone parents
* new candidate vaccine virus
● BX-53C reassortant has passed the one-way haemagglutination inhibition
test by the WHO Collaborating Centre for Reference and Research on
Influenza at CDC Atlanta, United States of America
Institutes contact details for candidate vaccine viruses' orders/information:
NIBSC: [email protected] or [email protected]
NIID: [email protected]
CDC:
[email protected]
NYMC: [email protected]
For general enquiries, please contact [email protected]
For other candidate vaccine viruses and potency testing reagents, please go to
http://www.who.int/influenza/vaccines/virus/en/
Page 2 of 2